Stay updated on Crescita Therapeutics Press Releases
Sign up to get notified when there's something new on the Crescita Therapeutics Press Releases page.

Latest updates to the Crescita Therapeutics Press Releases page
- Check7 days agoChange DetectedThe web page has undergone a minor numerical adjustment, with a slight decrease in values presented. However, there are no significant changes to core content, names, pricing, or availability.SummaryDifference5%
- Check14 days agoChange DetectedThe web page has undergone numerical adjustments, with a slight increase in one value and a decrease in another, indicating a minor change in data representation.SummaryDifference4%
- Check21 days agoChange DetectedCrescita Therapeutics has announced the results of its Annual General and Special Meeting of Shareholders, while the previous announcement regarding the approval of a Normal Course Issuer Bid has been removed.SummaryDifference59%
- Check28 days agoChange DetectedThe web page has seen a slight adjustment in numerical values, with a decrease in one metric and a minor increase in another. However, there are no significant changes to core content, names, pricing, or availability.SummaryDifference5%
- Check36 days agoChange DetectedCrescita Therapeutics has announced a mutual termination of its licensing agreement with Croma Pharma GmbH for Pliaglis®, along with several financial results reports for the first quarter and fiscal year 2024.SummaryDifference100%
- Check43 days agoChange DetectedThe page has been updated with recent financial results and announcements from Crescita, including their first quarter 2025 results and other significant corporate events.SummaryDifference100%
Stay in the know with updates to Crescita Therapeutics Press Releases
Enter your email address, and we'll notify you when there's something new on the Crescita Therapeutics Press Releases page.